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Abstract
In this study, a new in vitro continuous colonic fermentation model of Salmonella
infection with immobilized child fecal microbiota and Salmonella serovar Typhi-
murium was developed for the proximal colon. This model was then used to test
the effects of two amoxicillin concentrations (90 and 180mg day1) on the
microbial composition and metabolism of the gut microbiota and on Salmonella
serovar Typhimurium during a 43-day fermentation. Addition of gel beads (2%,
v/v) colonized with Salmonella serovar Typhimurium in the reactor resulted in a
high and stable Salmonella concentration (log 7.5 cell numbermL1) in effluent
samples, and a concomitant increase of Enterobacteriaeceae, Clostridium coccoides
–Eubacterium rectale and Atopobium populations and a decrease of bifidobacteria.
During amoxicillin treatments, Salmonella concentrations decreased while micro-
bial balance and activity were modified in agreement with in vivo data, with a
marked decrease in C. coccoides–E. rectale and an increase in Enterobacteriaceae.
After interruption of antibiotic addition, Salmonella concentration again increased
to reach values comparable to that measured before antibiotic treatments, showing
that our model can be used to simulate Salmonella shedding in children as
observed in vivo. This in vitro model could be a useful tool for developing and
testing new antimicrobials against enteropathogens.
Introduction
Salmonellosis is one of the most common and widely
distributed foodborne diseases worldwide. It is associated
with two types of symptoms, caused by different serovars of
Salmonella enterica ssp. enterica: typhoid fever (mainly
caused by serovar Typhi, Paratyphi and Sendai), which is
more common in developing countries, and gastroenteritis
(mainly caused by serovar Typhimurium and Enteritidis),
also encountered in developed countries (Coburn et al.,
2007). In Europe, 176 395 cases of salmonellosis infections
(i.e. 38 for 100 000 habitants) were reported in 2005, with a
major proportion (20%) of young children o 5 years of age
(The European Food Safety Authority & European Center
for Disease Prevention and Control, 2006). In children,
dehydration associated with diarrhea can become severe
and life-threatening (Rosanova et al., 2002); therefore,
effective antimicrobials are essential drugs for treatment.
Antimicrobials most widely regarded as optimal for treating
diarrheal diseases caused by Salmonella serovar Typhi-
murium in children are third-generation cephalosporins,
because quinolones and fluoroquinolones are generally not
recommended due to their toxicity on immature cartilage
and the possible emergence of resistant pathogens (Schaad,
2005). The earlier drugs, chloramphenicol, amipicillin,
amoxicillin and trimethoprim-sulfamethaoxazole, are also
used as alternatives (Frye & Fedorka-Cray, 2007; World
Health Organization, 2008). However, the emergence of
Salmonella isolates with multiple-drug resistance urges the
need for alternatives to antibiotherapies (White et al.,
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2001; World Health Organization, 2008). Valuable models of
Salmonella infection are therefore needed to develop
and test new treatments, in particular, for young human
populations.
To our knowledge, there is currently no suitable model
to test the effects of new antimicrobials on both entero-
pathogens and intestinal bacteria. Animal models such as
bovine or streptomycin-pretreated mice models for Salmo-
nella infection do not reproduce the human intestinal
microbiota and are dedicated to the study of host–pathogen
interactions (Hapfelmeier & Hardt, 2005). Moreover,
in vivo studies are difficult to perform due to the cost,
ethical problems and high interindividual variations. By
contrast, in vitro models are much less expensive, simpler
to handle and could be a good alternative for testing
new antimicrobial treatments in a first screening phase;
however, the current models are not suitable for intestinal
infections. The continuous culture models for human
intestinal microbiota are mainly based on the original
model of Macfarlane et al. (1998) and inoculated with
diluted feces. These systems have several limitations due
to the planktonic state of bacterial populations, leading
to limited microbial stability and cell density compared
with the colon; they are also not suited for long-term
experiments with enteropathogens because exogenous
bacteria are rapidly washed out of the system (Carman
& Woodburn, 2001; Blake et al., 2003; Payne et al.,
2003; Carman et al., 2004). Recently, we developed and
validated a new model of infant and adult colonic fer-
mentation with fecal microbiota immobilized in gel beads
in anaerobic continuous-flow cultures (Cinquin et al.,
2006a, b; Cleusix et al., 2008). This new model has condi-
tions that are more akin to that of the intestinal system and
has the following characteristics: bacteria growing in biofilm
structures; high cell density in gel beads and in reactor
effluents (up to 1011 cellsmL1 or g1); high stability and
reactivity to changing conditions of the intestinal fermenta-
tion; good protection of sensitive bacteria from shear and
oxygen stresses; and prevention of washout and loss of less
competitive bacteria.
In this study, we developed an in vitro model of
intestinal fermentation with immobilized feces simulating
intestinal Salmonella infections and long-term shedding
in children. We hypothesized that addition of colonized
beads with Salmonella serovar Typhimurium in the intest-
inal fermentation model containing an immobilized child
microbiota would cause a stable infection of Salmonella
in gel beads and in effluent samples. The effects of two
antibiotic treatments on Salmonella serovar Typhimurium,
as well as on the main bacterial populations and metabolism
of child microbiota were tested during the same continuous
culture and compared with in vivo data to validate the
model.
Materials and methods
Bacterial strain
Salmonella enterica ssp. enterica serovar TyphimuriumM557
(sseD::aphTDinvG) (S. Typhimurium) was supplied by Prof.
W. Hardt (Institute of Microbiology, ETH, Zurich, Switzer-
land). Sensitive to amoxicillin, this strain is a low virulent
derivative of S. Typhimurium wild-type strain SL1344 lack-
ing SPI-1 effector proteins (Hapfelmeier et al., 2004). It was
routinely cultivated in tryptone soya broth (TSB, Oxoid,
Basel, Switzerland) overnight at 37 1C in aerobiosis.
Antibiotic
In human practice, Clamoxyls/-RC (GlaxoSmithKline)
containing amoxicillin as active compound is a moderate-
spectrum b-lactam antibiotic that can be used to treat
salmonellosis in children (25–75mg kg1 day1) (Moulin
et al., 2003; Fachinformation des Arzneimittel-Kompen-
dium der Schweizs, 2007). It is bactericidal against a wide
range of Gram-positive and Gram-negative bacteria, includ-
ing sensitive Salmonella, with minimum inhibitory concen-
trations ranging from 1 to 5mgmL1 for 90% of tested
strains (Fachinformation des Arzneimittel-Kompendium
der Schweizs, 2007). For the experiment, pure amoxicillin
(Sigma-Aldrich, Buchs, Switzerland) was used.
Feces collection and bacterial immobilization
The fecal sample used for immobilization was collected from
a healthy 2-year-old child, who had not received antibiotics
at least 3 months before the experiment. The fecal sample
was maintained in anaerobiosis and immobilized in 1–2mm
gel beads composed of gellan (2.5%, w/v) and xanthan
(0.25%, w/v) gums and sodium citrate (0.2%, w/v), as
already described (Cleusix et al., 2008). Gel beads (60mL)
were then transferred into a stirred glass reactor (Sixfors,
Infors, Bottmingen, Switzerland) with 140mL of fresh
nutritive medium simulating a child chyme (presented
below). The entire process was completed under anaerobic
conditions within 3 h after defecation.
Salmonella Typhimurium immobilization was performed
1 day before reactor inoculation using the same procedure as
for fecal samples, but in aerobiosis under a sterile bench.
Salmonella beads (10mL) were colonized overnight in
200mL TSB at 37 1C in aerobiosis without pH control. A
fresh bead sample (0.5 g) was used to inoculate the reactor
on day 11 and the rest was stored frozen (0.5-g aliquots) in
20% glycerol at  80 1C.
Nutritive medium
The nutritive medium used to feed the reactor was similar to
that described previously by Macfarlane et al. (1998) for
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simulating an adult ileal chyme, with one modification; the
bile salt concentration was reduced from 0.4 to 0.05 g L1 to
reproduce the ileal chyme of a young child. A solution of
vitamins described by Michel et al. (1998) and sterilized by
filtration (Minisart 0.2 mm, Sartorius, Go¨ttingen, Germany)
was added (0.5mL L1) separately to the autoclaved
(15min, 121 1C) medium.
Experimental setup and sampling
A single-stage reactor based on the model described by
Cinquin et al. (2004) was used to mimic the microbial
ecosystem of a child’s proximal colon. Batch fermentations
were first carried out to colonize the fecal beads for 2 days.
During colonization, the nutritive medium was aseptically
replaced by a fresh nutritive medium every 12 h. Tempera-
ture (37 1C) was automatically controlled and pH was
maintained at 5.7 by adding NaOH (5N). Anaerobic condi-
tions were maintained during the whole fermentation by a
continuous flow of pure CO2 in the headspace. Continuous
fermentation was carried out in the same reactor connected
to a stirred feedstock vessel containing a sterile nutritive
medium continuously flushed with CO2 and maintained at
4 1C and to an effluent receiving vessel. Continuous medium
feeding was carried out using peristaltic pumps (Reglo
analog, Ismatec, Glattbrugg, Switzerland) delivering a feed
flow rate of 40mL h1 for a mean retention time of 5 h. This
duration of time was used to simulate the residence time in a
child proximal colon, with a pH of 5.7 (Fallingborg et al.,
1990).
The 43-day continuous fermentation was divided into six
periods of 5–9 days (Fig. 1). First, the system was stabilized
(STyphi 0; days 3–10), then 0.5 g of beads colonized with S.
Typhimurium (days 11 and 13) were added to the system,
followed by a second stabilization period (STyphi I; days
14–20) and two antibiotic treatments [ATB I (214 mgmL1
thrice a day); days 21–25 and ATB II (428mgmL1 thrice a
day); days 35–39] intercalated with a third stabilization
period without antibiotic (STyphi II, days 26–34). Amox-
icillin was added directly in the reactor three times per day
(at 09:00, 14:00 and 18:00 hours) to reach total concentra-
tions of 90mg day1 (ATB I) and 180mg day1 (ATB II).
According to the Fachinformation des Arzneimittel-Kompen-
dium Schweizs, the average oral dose (divided into three
doses) of Clamoxyls/-RC is 50mg kg1 day1 for young
children (2–12 year old), with an absorption rate between
70% and 90% in the gastrointestinal tract. On the basis of
two absorption rates of 70% and 85%, we calculated that
90–180mg day1 amoxicillin should reach the colon for a
12-kg child receiving 600mg amoxicillin day1. On the last
evening of ATB I (day 25) and II (day 39), the reactor was
briefly stopped and the medium was entirely pumped out of
the reactor after the beads had settled. A new medium
without an antibiotic (Stab II and III) was immediately
added. Effluent samples (10mL) were collected daily for
metabolite [short-chain fatty acids (SCFA), and lactate] and
FISH analyses. The pseudo steady state for each period was
considered to be reached when bacterial populations in the
reactor effluent did not change by 4 0.5 log units during
four consecutive days (Cinquin et al., 2006a, b).
During antibiotic treatments, effluent samples were col-
lected before adding the first daily antibiotic dose.
Bacterial enumeration with FISH and microscopy
FISH analyses coupled with microscopy were performed for
total bacteria and Salmonella enumeration as described by
Cinquin et al. (2006a) on fermentation samples (1.5mL)
from the last 3 days of each pseudo-steady-state period.
Total bacteria were stained with 40,6-diamidino-2-phenylin-
dole (Sigma-Aldrich) and S. Typhimurium was targeted
with Sal 3, a Cy3-labeled oligonucleotide probe (Micro-
synth, Balgach, Switzerland), with hybridization conditions
described by Nordentoft et al. (1997).
Bacterial enumeration with FISH and flow
cytometry
FISH analyses coupled with flow cytometry were performed
based on the method described by Zoetendal et al. (2002),
with some modifications. Briefly, 100 mL of fixed fermenta-
tion samples (1.5mL) and fixed feces (1.5mL) were centri-
fuged (9000 g, 3min) and the pellet was washed once in Tris-
EDTA buffer (100mM Tris/HCl, 500mM EDTA, pH 8)
before incubation for 10min at room temperature in
100 mL of Tris-EDTA buffer supplemented with lysozyme
(170 800UmL1) and proteinase K (6mgmL1) to destroy
protein clusters formed during both antibiotic treatment
periods that interfered with flow cytometry detection. After
removing the lysozyme solution by centrifugation (9000 g,
3min) and washing the pellet once with 100mL of fresh
hybridization buffer [900mM NaCl, 20mM Tris/HCl, 0.1%
sodium dodecyl sulfate (SDS), 30% formamide, pH 8], cells
Feces beads
30% (v/v)
STyphi IIISTyphi ISTyphi 0BC ATB I STyphi II ATB II
0
Salmonella
beads
2% (v/v) 
Amoxicillin
90 mg day    
Amoxicillin
180 mg day    
SB
3 11 13 21 25 35 39 43
Fig. 1. Time schedule of continuous intestinal fermentation experi-
ments during different treatment periods: BC, beads colonization; STyphi
0, stabilization of the system, days 3–10; SB, addition of Salmonella
Typhimurium M557 beads, days 11 and 13; STyphi I, stabilization of
S. Typhimurium M557 concentrations in effluent samples, days 14–20;
ATB I, daily addition of 90 mg amoxicillin, days 21–25; STyphi II, stabiliza-
tion period, days 26–34; ATB II, daily addition of 180 mg amoxicillin, days
35–39, STyphi III; stabilization period, days 40–43.
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were resuspended in 300 mL of hybridization buffer, homo-
genized and divided into 10 aliquots of 25 mL. With the
exception of the negative control, aliquots were hybridized
overnight at 35 1C with 50 ng mL1 of Cy5-labeled probes
(Table 1). Because hybridization conditions described for Sal
3 (Nordentoft et al., 1997) slightly differed from the condi-
tions used in flow cytometry, the Sal 3 probe specificity was
tested again with hybridization conditions used for flow
cytometry (Table 1).
After hybridization and to remove nonspecific binding of
probes, 900 mL of warm washing buffer (64mM NaCl,
20mM Tris/HCl, 5mM EDTA, 0.1% SDS, pH 8) was added
and samples were incubated at 37 1C for 20min. A last
centrifugation step was performed (9000 g, 3min) before
resuspending the pellet in 300 mL of cold potassium citrate
buffer (10mM Tris/HCl, 1mM EDTA, and 30mM potas-
sium citrate, pH 7.4). A 50-mL aliquot was diluted with
400 mL of potassium citrate buffer to obtain a final bacterial
concentration of about 108 bacteriamL1. A volume of
0.5 mL of diluted (1/10 000) SYBR Green I (Invitrogen AG,
Basel, CH) was added at least 15min before each measure-
ment in order to differentiate bacteria from nonbacterial
material. To determine bacterial cell numbers, 50mL of
Flow-CountTM Fluorospheres (Beckman Coulter Interna-
tional SA, Nyon, Switzerland) at known concentrations
(1012 beads mL1) were added just before data acquisition.
Samples were passed through a Cytomics FC 500 (Beckman
Coulter International SA) equipped with an air-cooled
argon ion laser emitting 20mW at 488 nm and a Red Solid
State Diode laser emitting 25mW at 633 nm. The 633 nm
laser was used to detect red fluorescence of bacteria hybri-
dized with Cy5-labeled probes (PMT4 in a 655 nm long pass
filter) and the 488 nm laser was used to measure the forward
angle light scatter, the side angle light scatter and the green
fluorescence conferred by SYBR Green I (PMT1 in a 525 nm
band pass filter). The acquisition threshold was set in the
forward scatter channel to the minimum. The flow rate was
set at 1000–3000 events s1, and 100 000 events were stored
in list mode files. Data were analyzed using the CXP software
(Beckman Coulter International SA). A PMT1 histogram
(green fluorescence) was used to evaluate the total number
of bacteria stained with SYBR Green I. In this histogram, a
gate that included the total number of bacterial cells in the
sample was designed and used to make a PMT4 histogram
(red fluorescence). This PMT4 histogram was then used to
determine the bacterial groups marked with Cy5-labeled
probes. To quantify bacterial groups and total cells, a
correction was made to eliminate background fluorescence,
measured using the negative control NON-EUB338-Cy5
probe, as described by Rigottier-Gois et al. (2003). Analyses
were performed in duplicate.
Metabolite analyses
SCFA (acetate, propionate, butyrate and formate) and
lactate concentrations were determined by HPLC as de-
scribed previously (Cleusix et al., 2008). Each analysis was
performed in duplicate. The mean metabolite concentra-
tions were expressed in millimolar.
Statistical analyses
A one-way ANOVA was performed using SPSS 13.0 for Win-
dows (SPSS Inc., Chicago, IL) to test the effects of the
different treatments on the bacterial and metabolite con-
centrations measured during the pseudo-steady-state peri-
ods (mean of three successive days) in effluent samples.
Treatment means were compared using Tukey’s test, with the
probability level of Po 0.05. Data in the text are
means SD.
Results
Microbial populations analyzed by FISH-flow
cytometry
The child fecal sample used for immobilization showed a
total population of 10.2 0.1 log10 cells g1, and was highly
dominated by bifidobacteria (9.8 0.1 log10 cells g1). The
Table 1. Oligonucleotide probes and hybridization conditions used to target predominant bacterial groups
Probes Dyes Target organisms Formamide (%) Temperature ( 1C) Probe references
Sal 3 Cy-3 Salmonella enterica 0 45 Nordentoft et al. (1997)
NonEub338 Cy-5 NA 30 35 Wallner et al. (1993)
Bif 164 Cy-5 Bifidobacterium 30 35 Langendijk et al. (1995)
Bac 303 Cy-5 Bacteroides-Prevotella 30 35 Manz et al. (1996)
Erec 482 Cy-5 C. coccoides–E. rectale 30 35 Franks et al. (1998)
Ato 291 Cy-5 Atopobium 30 35 Harmsen et al. (2000)
Enter 432 Cy-5 Enterobacteria 30 35 Sghir et al. (2000)
Sal 3 Cy-5 Salmonella 30 35 Nordentoft et al. (1997)
The oligonucleotide probe labeled at the 50 end with Cy-3 was detected with microscopy whereas Cy-5 labeled probes were used in flow cytometry.
DAPI and SYBR green I-stains were used for total bacteria enumeration in microscopy and flow cytometry, respectively.
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mean concentrations of major bacterial populations
measured in protease-treated fermentation samples by
FISH-flow cytometry during the last 3 days of each experi-
mental period are shown in Table 2. The predominant
bacterial genus in the reactor effluents during the whole
fermentation (except during STyphi I) was Bifidobacterium
spp., initially followed by Clostridium coccoides–Eubacterium
rectale and Bacteroides–Prevotella groups. No Salmonella or
other Enterobacteriaceae were detected during STyphi 0.
Following addition of S. Typhimurium-colonized beads
(11.1 log10 cells g
1 bead) to the reactor (days 11 and 13;
STyphi I), a high concentration of Salmonella (7.5
0.1 log10 cellsmL
1) was measured in effluent samples at
the end of the first stabilization period (STyphi I, Table 2).
Furthermore, the intestinal microbial balance largely
changed compared with STyphi 0, with a significant decrease
of bifidobacteria ( 1.2 log10 unit) and a significant increase
of Enterobacteriaceae, Atopobium spp. and the C. cocco-
ides–E. rectale group. During this period (STyphi I), the
C. coccoides–E. rectale group became the predominant
bacterial group. Addition of amoxicillin (90mg day1, ATB
I) induced a significant decrease in Salmonella concentra-
tion (4 1.5 log10 units) compared with STyphi I (Table 2)
and a shift in the different bacterial concentrations, which
reverted to values not significantly different from STyphi 0
(P4 0.05). The only exception was Enterobacteriaceae,
which, in contrast to Salmonella, did not decrease during
ATB I and remained significantly higher than during
STyphi 0. During STyphi II with no antibiotic, most
bacterial populations (including Salmonella) reverted to
values similar to STyphi I, except for Bifidobacterium spp.
and C. coccoides–E. rectale concentrations, which were sig-
nificantly higher and lower, respectively. The second amox-
icillin treatment (180mg day1, ATB II) induced similar
changes as during ATB I, but the effects on bacterial
populations measured during the last 3 days were significant
only for Salmonella and the C. coccoides–E. rectale group.
Finally, during the last stabilization period without an
antibiotic (STyphi III), bacterial populations reverted to
values similar to STyphi 0, except for Salmonella and total
Enterobacteriaceae, which remained significantly higher than
for STyphi 0 and equal to STyphi I. No effect of treatments
was observed on total bacteria or on Bacteroides concentra-
tions during the whole fermentation.
Microbial populations analyzed by FISH
microscopy
Bacterial analyses with FISH coupled to microscopic counts
for total bacteria and S. Typhimurium used to monitor over
time the fermentation process corroborated data obtained
with flow cytometry, with a significant decrease in Salmo-
nella concentration during ATB I and II. No protease
treatment was applied to these samples. However, a more
pronounced inhibition of S. Typhimurium was measured
with ATB I ( 1.3 log10 units compared with STyphi I)
compared with ATB II ( 0.95 log10 units compared with
STyphi II) (Fig. 2). Furthermore, cell aggregation was
enhanced during antibiotic treatments. The total bacteria
counts measured with FISH microscopy were significantly
lower ( 1.2 log10 units) than by FISH flow cytometry,
decreased from STyphi 0 to STyphi I and remained stable
during the subsequent treatments.
Metabolites analyses
The profiles of metabolite concentrations during the differ-
ent fermentation periods are shown in Fig. 3. Acetate was
the main metabolite detected during STyphi 0 and through-
out the fermentation (40–80mM), whereas propionate and
butyrate were present at low concentrations ( 20mM).
Lactate was also detected, although in variable concentra-
tions (1–20mM), during the whole fermentation. Addition
of S. Typhimurium induced a significant increase in buty-
rate (6.0 0.1 and 13.5 1.8mM for STyphi 0 and STyphi I,
respectively), whereas the other metabolites were not mod-
ified between the two periods (Table 3). ATB I drastically
Table 2. Bacterial populations in fermentation samples during pseudo steady states of each treatment period measured by FISH-flow cytometry
Bacterial populations
Bacterial counts (log10 cells mL
1 medium)
STyphi 0 STyphi I ATB I STyphi II ATB II STyphi III
Bifidobacterium 10.20.1c 9.0 0.2a 10.5 0.3c 9.9 0.3bc 9.7 0.5ab 10.3 0.1c
C. coccoides–E. rectale 9.10.1bc 10.3 0.3d 8.5 0.1ab 9.5 0.3c 8.4 0.4a 8.5 0.4ab
Bacteroides 8.80.2a 9.0 0.2a 9.0 0.5a 9.0 0.2a 8.6 0.1a 9.0 0.02a
Atopobium 7.30.04a 9.2 0.1c 7.5 0.4a 8.7 0.3bc 8.0 0.5ab 7.2 0.7a
Enterobacteriaceae NDw 8.9 0.2b 8.2 0.3ab 8.3 0.2ab 7.4 0.3a 9.4 0.3b
Salmonella ND 7.5 0.1a ND 8.1 0.2a ND 7.6 0.2a
Total bacteria 10.30.4a 10.4 0.2a 10.5 0.1a 10.3 0.1a 10.0 0.3b 10.4 0.2a
Data are means SD for the last 3 days for each fermentation period, n= 2. Values with different letters in a row are significantly different with Tukey’s
test, Po 0.05.
wND, not detected, below detection limit of the method (log10 6 cells mL
1).
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decreased the total metabolite concentration compared
with STyphi I, especially due to a strong decrease in acetate,
while formate and lactate increased. During STyphi II,
metabolite concentrations reverted to their previous levels
of STyphi I, except for acetate and butyrate, which remained
significantly lower than during STyphi I. ATB II induced
slightly different metabolite concentration changes com-
pared with ATB I. A less pronounced decrease in acetate
concentration was observed, whereas lactate and formate
were significantly more increased. During the last stabiliza-
tion period (STyphi III), metabolite concentrations reverted
to their previous levels of STyphi II, except for propionate
and formate (Table 3).
Discussion
Recently, we successfully developed a new in vitro model of
intestinal fermentation with immobilized fecal microbiota
(Cinquin et al., 2004, 2006a, b; Cleusix et al., 2008). One
major advantage of cell immobilization in intestinal fermen-
tation models is the very high microbial and metabolic
stability due to entrapment and growth of fecal microbiota
in polysaccharide beads, which was tested over long fermen-
tation periods (up to 7 weeks).
In this study, we used the same approach with fecal
sample immobilization and continuous fermentation to
develop an original model simulating Salmonella gut infec-
tion in children. We showed that cell immobilization can
circumvent problems due to washout of exogenous enter-
opathogens observed in conventional in vitro intestinal
fermentation models operated with planktonic cells (Blake
et al., 2003; Payne et al., 2003; Carman et al., 2004).
According to our initial assumption, addition of S. Typhi-
murium immobilized in polysaccharide beads allowed to
recover and maintain S. Typhimurium in the reactor
effluents during the entire fermentation of 43 days.
Seven days after addition of S. Typhimurium colonized
beads (days 18–20; STyphi I), the strain was detected at
high concentrations (7.5 log10 cellsmL
1) in effluent sam-
ples, in agreement with in vivo concentrations of nonty-
phoid Salmonella shedding of up to 106–107 organisms g1
of feces measured in some children during early con-
valescence (Cruickshank & Humphrey, 1987). Salmonella
Typhimurium and commensal bacteria were analyzed daily
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in effluent samples during the 43-day fermentation. A
protease treatment was used to destroy aggregates before
bacterial enumeration with FISH-flow cytometry. However,
no sample protease treatment was performed before analysis
with FISH microscopy. Therefore, the aggregation phenom-
ena can explain the lower total and Salmonella cell counts
detected with FISH microscopy compared with FISH-flow
cytometry. Furthermore, the higher inhibition effects of
antibiotics on Salmonella detected with FISH microscopy
compared with FISH flow cytometry could also be due
to enhanced cell aggregation observed during antibiotic
treatments.
Total bacteria and bifidobacteria populations measured
during STyphi 0 and in feces were high and very close.
Unfortunately, the other populations could not be deter-
mined in feces due to lack of samples. We showed in
previous studies that the main populations of child and
adult fecal samples were well preserved during immobiliza-
tion and long-term continuous fermentation. However,
differences in the microbial balance between the fecal
inoculum and the reactor effluents occurred due to changes
in the environmental conditions between the host intestine
and the fermentation model, such as medium composition,
pH and retention time (Cinquin et al., 2004, 2006b; Cleusix
et al., 2008). Such differences are often observed with in vitro
intestinal fermentation systems (Macfarlane & Macfarlane,
2007). Furthermore, conditions of the proximal colon
applied in the fermentation model are very different from
those of the distal colon, where the composition of fecal
material is more similar to feces. Compared with STyphi 0,
S. Typhimurium colonization (STyphi I) induced a strong
modification in the microbial balance. Bifidobacteria, pre-
sent in high numbers during STyphi 0, were significantly
decreased, whereas the C. cocoides–E. rectale group and
Atopobium spp. were strongly increased (Po 0.05). In
contrast to bacterial populations, metabolites were only
slightly modified, with only a significant increase in butyrate
concentrations during STyphi I. This butyrate accumulation
may be explained by an increase in the C. cocoides–E. rectale
group, which contains most of the butyrate producers
(Barcenilla et al., 2000).
As expected, addition of amoxicillin in the reactor
significantly reduced S. Typhimurium concentration in
effluent samples and changed the microbial balance.
C. coccoides–E. rectale and Atopobium populations were
strongly inhibited by amoxicillin, whereas Bacteroides, bifi-
dobacteria and total Enterobacteriaceae were not affected.
Marked decreases in the C. cocoides–E. rectale group have
already been described by Barc et al. (2004) in human fecal
flora-associated mice receiving amoxicillin–clavulanic acid
(150mg kg1 body weight) for 7 days. The lack of activity of
amoxicillin on Bacteroides–Prevotella and Enterobacteriaceae
was also expected because it is known that certain Bacter-
oides such as Bacteroides fragilis and some Enterobacteriaceae
(Klebsiella spp., Escherichia coli) are not inhibited during
amoxicillin treatments in humans (Floor et al., 1994;
Sullivan et al., 2001). Indeed, resistance to b-lactams via
b-lactamase production has largely been described in Bac-
teroides spp. and Enterobacteriaceae (Kader et al., 2004;
Papaparaskevas et al., 2005).
Unexpectedly, bifidobacteria were not inhibited by amox-
icillin treatments and their growth was even stimulated
during ATB I. Although it is generally admitted that
bifidobacteria are highly sensitive to b-lactams (Moubareck
et al., 2005), some strains are resistant to amoxicillin (Lim
et al., 1993; Vlkova´ et al., 2006). However, bifidobacteria
overgrowth during ATB I may not be directly associated
with the effects of antibiotics. It could also be due to the
strong decrease in the C. coccoides–E. rectale group, which
allowed the growth of bifidobacteria to similar high levels as
tested during STyphi 0. Bifidobacteria that were particularly
competitive in the system may have prevented the over-
growth of Bacteroides spp. during amoxicillin treatment as
observed previously in vivo (Christensson et al., 1991).
Enterobacteriaceae were not significantly decreased during
ATB I and ATB II despite a significant decrease of Salmo-
nella, and became the second most dominant group during
STyphi II, at the expense of the C. coccoides–E rectale group.
Table 3. Metabolite concentrations in effluent samples during pseudo-steady states of each treatment period measured by HPLC
Metabolites
Metabolite concentration (mM)
STyphi 0 STyphi I ATB I STyphi II ATB II STyphi III
Acetate 69.6 2.1bc 72.5 3.6c 45.9 5.1a 63.62.7b 50.13.7a 64.8 1.7bc
Propionate 5.2 0.5b 6.1 2.0bc 6.2 0.6bc 7.51.0c 2.20.4a 3.8 0.2ab
Butyrate 6.0 0.1ab 13.5 1.8c 13.3 2.6c 8.21.5b 3.91.5a 7.9 1.5ab
Formate NDaw NDa 3.8 0.8b NDa 7.21.8bc 10.5 1.4c
Lactate 1.3 0.2a 1.2 0.4a 7.9 1.0b 2.00.5a 17.13.0c 4.1 1.6d
Total metabolites 82.1 1.6abc 93.3 4.0c 77.1 4.2a 81.32.4abc 80.55.1ab 91.2 3.5bc
Data are means SD for the last 3 days for each fermentation period, n= 2. Values with different letters in a row are significantly different with Tukey’s
test, Po 0.05.
wND, not detected, below detection limit of the method.
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Such increases in Enterobacteriaceae have also been fre-
quently described in the literature after amoxicillin treat-
ments in humans (Christensson et al., 1991; Sullivan et al.,
2001).
In parallel to modifications of microbial balance during
ATB I and II, metabolite ratios were also strongly modified.
ATB I decreased acetate and increased lactate and formate
concentrations, whereas butyrate and propionate were not
changed compared with STyphi I. Doubling the amoxicillin
concentration (ATB II) also led to a similar decrease in
acetate concentration compared with STyphi II, but also to
twice as much lactate and formate and to a decrease in
propionate and butyrate concentrations. Lactate and for-
mate are intermediate metabolites produced by many dif-
ferent bacteria (Cummings & Macfarlane, 1991), further
metabolized by other bacteria into CO2 and major SCFA
(acetate, propionate or butyrate) (Seeliger et al., 2002;
Duncan et al., 2004). These metabolites generally do not
accumulate in the human colon (Bernalier et al., 1999).
Their accumulation, together with the changes in SCFA
ratios during ABT I and II, suggest that lactate- and formate-
utilizing bacteria were inactivated during amoxicillin treat-
ments. The marked decrease in the C. cocoides–E. rectale
group, which harbors many lactate-utilizing bacteria (Dun-
can et al., 2004), is likely responsible for lactate accumula-
tion during these periods.
Immobilization of S. Typhimurium and its addition to
the recently developed in vitro model of intestinal fermenta-
tion with immobilized fecal microbiota led to stable high
levels of S. Typhimurium in the effluent of the continuous
gut reactor, simulating Salmonella shedding observed in
certain children. Moreover, immobilization prevented wash-
out of S. Typhimurium during antibiotic treatments, which
allowed comparison of two treatments during the same
fermentation with the same fecal inoculum. The effects of
amoxicillin measured with this new in vitro colonic fermen-
tation model for Salmonella infections are in agreement
with in vivo observations showing a high disturbance of
the intestinal microbiota balance with decreases in the
C. coccoides–E. rectale group and increases in Enterobacter-
iaceae ratios. Furthermore, metabolic ratios tested in the in
vitro model correlated with microbial change, providing
further validation of this model. Therefore, this new model
is a promising tool for simulating intestinal infections in
humans with the aim of developing and testing the effects of
different antimicrobials on intestinal enteropathogens as
well as commensal bacteria.
Acknowledgement
This research was supported by a grant from the Swiss
National Science Foundation (SNF) (project number:
3100170-114028).
Authors’contribution
G.L.B. and J.R. contributed equally to this work.
References
Barc MC, Bourlioux F, Rigottier-Gois L, Charrin-Sarnel C,
Janoir C, Boureau H, Dore´ J & Collignon A (2004) Effect of
amoxicillin-clavulanic acid on human fecal flora in a
gnotobiotic mouse model assessed with fluorescence
hybridization using group-specific 16S rRNA probes in
combination with flow cytometry. Antimicrob Agents Ch 48:
1365–1368.
Barcenilla A, Pryde SE, Martin JC, Duncan SH, Stewart CS,
Henderson C & Flint HJ (2000) Phylogenetic relationships of
butyrate-producing bacteria from the human gut. Appl
Environ Microb 66: 1654–1661.
Bernalier A, Dore J & Durand M (1999) Biochemistry of
fermentation. Colonic Microbiota, Nutrition and Health
(Gibson GR & Roberfroid MB, eds), pp. 37–53. Kluwer
Academic Publishers, London.
Blake DP, Hillman K & Fenlon DR (2003) The use of a model
ileum to investigate the effects of novel and existing
antimicrobials on indigenous porcine gastrointestinal
microflora: using vancomycin as an example. Anim Feed Sci
Tech 103: 123–139.
Carman RJ & Woodburn MA (2001) Effects of low levels of
ciprofloxacin on a chemostat model of the human colonic
microflora. Regul Toxicol Pharm 33: 276–284.
Carman RJ, Simon MA, Fernandez H, Miller MA & Bartholomew
MJ (2004) Ciprofloxacin at low levels disrupts colonization
resistance of human fecal microflora growing in chemostats.
Regul Toxicol Pharmacol 40: 319–326.
Christensson B, Nilsson-Ehle I, Ljungberg B et al. (1991) A
randomized multicenter trial to compare the influence of
cefaclor and amoxycillin on the colonization resistance of the
digestive tract in patients with lower respiratory tract
infection. Infection 19: 208–215.
Cinquin C, Le Blay G, Fliss I & Lacroix C (2004) Immobilization
of infant fecal microbiota and utilization in an in vitro colonic
fermentation model. Microb Ecol 48: 128–138.
Cinquin C, Le Blay G, Fliss I & Lacroix C (2006a) Comparative
effects of exopolysaccharides from lactic acid bacteria and
fructo-oligosaccharides on infant gut microbiota tested in an
in vitro colonic model with immobilized cells. FEMS Microbiol
Ecol 57: 226–238.
Cinquin C, Le Blay G, Fliss I & Lacroix C (2006b) New three-stage
in vitro model for infant colonic fermentation with
immobilized fecal microbiota. FEMS Microbiol Ecol 57:
324–336.
Cleusix V, Lacroix C, Vollenweider S & Le Blay G (2008) Glycerol
induces reuterin production and decreases Escherichia coli
population in an in vitro model of colonic fermentation with
immobilized human feces. FEMS Microbiol Ecol 63: 56–64.
Coburn B, Grassl GA & Finlay BB (2007) Salmonella, the host and
disease: a brief review. Immunol Cell Biol 85: 112–118.
FEMS Microbiol Ecol 67 (2009) 198–207 c 2008 Federation of European Microbiological Societies
Published by Blackwell Publishing Ltd. All rights reserved
205In vitro salmonellosis model
Cruickshank JG & Humphrey TJ (1987) The carrier food-handler
and non-typhoid salmonellosis. Epidemiol Infect 98: 223–230.
Cummings JH & Macfarlane GT (1991) The control and
consequences of bacterial fermentation in the human colon.
J Appl Bacteriol 70: 443–459.
Duncan SH, Louis P & Flint HJ (2004) Lactate-utilizing bacteria,
isolated from human feces, that produce butyrate as a major
fermentation product. Appl Environ Microb 70: 5810–5817.
Fachinformation des Arzneimittel-Kompendium der Schweiz
(2007) Clamoxyls/-RC (GlaxoSmithKline). http://www.
kompendium.ch/Monographie.aspx?Id=8553f7cf-bda5-4841-
baed-86f3a7e32b27&lang=de&MonType=fi
Fallingborg J, Christensen LA, Ingeman-Nielsen M, Jacobsen BA,
Abildgaard K, Rasmussen HH & Rasmussen SN (1990)
Measurement of gastrointestinal pH and regional transit times
in normal children. J Pediatr Gastr Nutr 11: 211–214.
Floor M, van Akkeren F, Rozenberg-Arska M, Visser M, Kolsters
A, Beumer H & Verhoef J (1994) Effect of loracarbef and
amoxicillin on the oropharyngeal and intestinal microflora of
patients with bronchitis. Scand J Infect Dis 26: 191–197.
Franks AH, Harmsen HJ, Raangs GC, Jansen GJ, Schut F &
Welling GW (1998) Variations of bacterial populations in
human feces measured by fluorescent in situ hybridization
with group-specific 16S rRNA-targeted oligonucleotide
probes. Appl Environ Microb 64: 3336–3345.
Frye JG & Fedorka-Cray PJ (2007) Prevalence, distribution and
characterisation of ceftiofur resistance in Salmonella enterica
isolated from animals in the USA from 1999 to 2003. Int J
Antimicrob Ag 30: 134–142.
Hapfelmeier S & Hardt WD (2005) A mouse model for S.
typhimurium-induced enterocolitis. Trends Microbiol 13:
497–503.
Hapfelmeier S, Ehrbar K, Stecher B, Barthel M, Kremer M &
Hardt WD (2004) Role of the Salmonella pathogenicity island
1 effector proteins SipA, SopB, SopE, and SopE2 in Salmonella
enterica subspecies 1 serovar Typhimurium colitis in
streptomycin-pretreated mice. Infect Immun 72: 795–809.
Harmsen HJM, Wildeboer-Veloo ACM, Grijpstra J, Knol J,
Degener JE & Welling GW (2000) Development of 16S rRNA-
based probes for the Coriobacterium group and the Atopobium
cluster and their application for enumeration of
Coriobacteriaceae in human feces from volunteers of different
age groups. Appl Environ Microb 66: 4523–4527.
Kader AA, Kumar A & Dass SM (2004) Antimicrobial resistance
patterns of gram-negative bacteria isolated from urine
cultures at a general hospital. Saudi J Kidney Dis Transpl 15:
135–139.
Langendijk PS, Schut F, Jansen GJ, Raangs GC, Kamphuis GR,
Wilkinson MH & Welling GW (1995) Quantitative
fluorescence in situ hybridization of Bifidobacterium spp. with
genus-specific 16S rRNA-targeted probes and its application in
fecal samples. Appl Environ Microb 61: 3069–3075.
Lim KS, Huh CS & Baek YJ (1993) Antimicrobial susceptibility of
bifidobacteria. J Dairy Sci 76: 2168–2174.
Macfarlane GT & Macfarlane S (2007) Models for intestinal
fermentation: association between food components, delivery
systems, bioavailability and functional interactions in the gut.
Curr Opin Biotech 18: 156–162.
Macfarlane GT, Macfarlane S & Gibson GR (1998) Validation of a
three-stage compound continuous culture system for
investigating the effect of retention time on the ecology and
metabolism of bacteria in the human colon. Microb Ecol 35:
180–187.
Manz W, Amann R, Ludwig W, Vancanneyt M & Schleifer KH
(1996) Application of a suite of 16S rRNA-specific
oligonucleotide probes designed to investigate bacteria of the
phylum cytophaga-flavobacter-bacteroides in the natural
environment. Microbiology 142: 1097–1106.
Michel C, Kravtchenko TP, David A, Gueneau S, Kozlowski F &
Cherbut C (1998) In vitro prebiotic effects of Acacia gums
onto the human intestinal microbiota depends on both origin
and environmental pH. Anaerobe 4: 257–266.
Moubareck C, Gavini F, Vaugien L, Butel MJ & Doucet-Populaire
F (2005) Antimicrobial susceptibility of bifidobacteria.
J Antimicrob Chemoth 55: 38–44.
Moulin F, Sauve-Martin H, Marc E, Lorrot MM, Soulier M,
Ravilly S, Raymond J & Gendrel D (2003) Ciprofloxacin after
clinical failure of beta-lactam antibiotics in children with
salmonellosis. Arch Pediatrie 10: 608–614.
Nordentoft S, Christensen H & Wegener HC (1997) Evaluation
of a fluorescence-labelled oligonucleotide probe targeting
23S rRNA for in situ detection of Salmonella serovars in
paraffin-embedded tissue sections and their rapid
identification in bacterial smears. J Clin Microbiol 35:
2642–2648.
Papaparaskevas J, Pantazatou A, Katsandri A, Legakis NJ &
Avlamis Athe Hellenic Study Group for Gram-Negative
Anaerobic Bacteria (2005) Multicentre survey of the in vitro
activity of seven antimicrobial agents, including ertapenem,
against recently isolated Gram-negative anaerobic bacteria in
Greece. Clin Microbiol Infec 11: 820–824.
Payne S, Gibson G, Wynne A, Hudspith B, Brostoff J & Tuohy K
(2003) In vitro studies on colonization resistance of the human
gut microbiota to Candida albicans and the effects of
tetracycline and Lactobacillus plantarum LPK. Curr Issues
Intest Microbiol 4: 1–8.
Rigottier-Gois L, Le Bourhis A-G, Gramet G, Rochet V & Dore´ J
(2003) Fluorescent hybridisation combined with flow
cytometry and hybridisation of total RNA to analyse the
composition of microbial communities in human faeces using
16S rRNA probes. FEMS Microb Ecol 43: 237–245.
Rosanova MT, Paganini H, Bologna R, Lopardo H & Ensinck G
(2002) Risk factors for mortality caused by nontyphoidal
Salmonella sp. in children. Int J Infect Dis 6: 187–190.
Schaad UB (2005) Fluoroquinolone antibiotics in infants and
children. Infect Dis Clin N Am 19: 617–628.
Seeliger S, Janssen PH & Schink B (2002) Energetics and kinetics
of lactate fermentation to acetate and propionate via
FEMS Microbiol Ecol 67 (2009) 198–207c 2008 Federation of European Microbiological Societies
Published by Blackwell Publishing Ltd. All rights reserved
206 G. Le Blay et al.
methylmalonyl-CoA or acrylyl-CoA. FEMS Microbiol Lett 211:
65–70.
Sghir A, Gramet G, Suau A, Rochet V, Pochart P & Dore J (2000)
Quantification of bacterial groups within human fecal flora by
oligonucleotide probe hybridization. Appl Environ Microb 66:
2263–2266.
Sullivan A, Edlund C & Nord CE (2001) Effect of antimicrobial
agents on the ecological balance of human microflora. Lancet
Infect Dis 1: 101–114.
The European Food Safety Authority & European Center for
Disease Prevention and Control (2006) The community
summary report on trends and sources of zoonoses, zoonotic
agents, antimicrobial resistance and foodborne outbreaks in
the European Union in 2005. EFSA J 94: 1–236.
Vlkova´ E, Rada V, Popela´rˇova´ P, Trojanova´ I & Killer J
(2006) Antimicrobial susceptibility of bifidobacteria isolated
from gastrointestinal tract of calves. Livestock Sci 105:
253–259.
Wallner G, Amann R & Beisker W (1993) Optimizing fluorescent
in situ hybridization with ribosomal-RNA-targeted
oligonucleotide probes for flow cytometric identification of
microorganisms. Cytometry 14: 136–143.
White DG, Zhao S, Sudler R, Ayers S, Friedman S, Chen S,
McDermott PF, McDermott S, Wagner DD & Meng J
(2001) The isolation of antibiotic-resistant Salmonella
from retail ground meats. New Engl J Med 345: 1147–
1154.
World Health Organisation (2008) Drug-resistant Salmonella
(Fact sheet No 139). http://www.who.int/mediacentre/
factsheets/fs139/en/index.html
Zoetendal EG, Ben-Amor K, Harmsen HJ, Schut F, Akkermans
AD & de Vos WM (2002) Quantification of uncultured
Ruminococcus obeum-like bacteria in human fecal samples
by fluorescent in situ hybridization and flow cytometry using
16S rRNA-targeted probes. Appl Environ Microb 68:
4225–4232.
FEMS Microbiol Ecol 67 (2009) 198–207 c 2008 Federation of European Microbiological Societies
Published by Blackwell Publishing Ltd. All rights reserved
207In vitro salmonellosis model
